MedTrace Logo

Copeptin- Relevance as a Perioperative Marker in Pediatric Cardiac Surgery

NCT03316508 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 81

Last updated 2019-09-11

No results posted yet for this study

Summary

This study evaluates the relevance of Copeptin in children with congenital heart disease undergoing cardiac surgery with the need of cardiopulmonary bypass. Three blood samples are taken of each patient. The first and second sample are collected in the operation room before and after the procedure and the third sample on the first postoperative day at the intensive care unit.

Conditions

  • Congenital Heart Disease

Sponsors & Collaborators

  • Claudia Herbst

    lead OTHER

Principal Investigators

  • Claudia R Herbst, MD · Medical University Vienna Department for Cardiac Surgery

Eligibility

Max Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-14
Primary Completion
2018-10-01
Completion
2019-08-10

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03316508 on ClinicalTrials.gov